Generation of new biodegradable, drug-like molecules through re-designing certain moieties from known drug molecules while preserving their pharmacophore.
No takes yet. Share an insight, caveat, or question.
Rastogi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: